Early study suggests a new, injectable gel may greatly reduce chronic low back pain

Imaging-guided procedure could potentially offer a new treatment for degenerative disc disease

FAIRFAX, Va. (June 8, 2022)—An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back pain caused by degenerative disc disease (DDD), according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting, in Boston. Hydrogels have been used for a number of years to treat DDD, but the current study is the first test of this particular gel in humans.

Read the full press release here >